A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study to Evaluate the Efficacy and Safety of E2007 in Migraine Prophylaxis
Latest Information Update: 17 Jun 2015
Price :
$35 *
At a glance
- Drugs Perampanel (Primary)
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 09 Sep 2009 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
- 09 Sep 2009 Actual end date (Jun 2006) added as reported by ClinicalTrials.gov.
- 25 Jul 2007 Status changed from in progress to completed.